WHO ICTRP trial
Dexmedetomidine for saphenous nerve blockade! in patients undergoing anterior…
DRKS00010109 · German Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | DRKS00010109 |
|---|---|
| Public title | Dexmedetomidine for saphenous nerve blockade! in patients undergoing anterior cruciate ligament replacement:A randomized, placebo-controlled, Triple'Blinded'Study |
| Scientific title | Dexmedetomidine for saphenous nerve blockade! in patients undergoing anterior cruciate ligament replacement:A randomized, placebo-controlled, Triple'Blinded'Study - Dexmedetomidine for nervus saphenous block |
| Primary sponsor | UKH Salzburg |
| Registry | German Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | interventional |
| Phase | 2 |
| Countries | Austria |
| Conditions | M23.61;M23.61 |
| Interventions | Group 1: Saphenous nerve bloock with 10 ml ropivacaine 0,75 mg ml-1 plus 100 µg dexmedetomdine (consisting of 1ml) Group 2: Saphenous nerve block with 10 ml ropivacaine 0,75 mg ml-1 plus 1 ml of normal saline as placebo |
| Registration date | Feb 3, 2016 |
| Target size | 40 |
| Secondary IDs | 2014-000299-25 |
| Registry page | drks.de |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: